Agis, H <br/><br/>
In vivo effects of imatinib mesylate on human haematopoietic progenitor cells.  [electronic resource] 

 -  European journal of clinical investigation  Jun 2006 
 - 402-8 p.  digital 
<br/><br/> Publication Type: Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0014-2972 
<br/><br/><label>Standard No.: </label>10.1111/j.1365-2362.2006.01645.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antineoplastic Agents--pharmacology<br/>Benzamides<br/>Brain Neoplasms--blood<br/>Female<br/>Follow-Up Studies<br/>Hematopoiesis--drug effects<br/>Hematopoietic Stem Cells--drug effects<br/>Humans<br/>Imatinib Mesylate<br/>Leukemia, Myelogenous, Chronic, BCR-ABL Positive--blood<br/>Male<br/>Middle Aged<br/>Piperazines--pharmacology<br/>Protein Kinase Inhibitors--pharmacology<br/>Protein-Tyrosine Kinases--antagonists & inhibitors<br/>Pyrimidines--pharmacology<br/>Treatment Outcome